Founded in 2009, Celmatix is a personalized medicine company focused on fertility and women’s health. Named one of Fast Company's "50 Most Innovative Companies in 2017," Celmatix is changing the face of women’s health through the development of digital tools and genetic insights focused on fertility potential. Our unique approach combines data science and genomics to bring personalized medicine to fertility. Our leadership team includes a diverse group of world-class scientists and professionals including a founder recently recognized by Fortune Magazine as one of 15 Entrepreneurs Disrupting their Industries, Inc Magazine’s 10 Women to Watch in Tech, and named an Aspen Institute’s Health Innovator Fellow, and a NYC Venture Fellow by the NYCEDC.